View in-depth analysis for preclinical tumor models and tech in these spotlights by our scientists.
Exploring orthotopic glioblastoma models to treat tumors and strengthen immune responses in the brain
Plate-based 3D culture assays that mimic the tumor microenvironment and predict in vivo responses
A deeper dive into the tumor-infiltrating T Cell immunophenotype
Absolute counts by flow cytometry — maximize the accuracy of your immunophenotypic data interpretation
Comprehensive dendritic cell analysis by flow cytometry using the new CompDC™ panel
Multiplex IHC for patterns of protein expression, co-expression, and spatial relationships
PRECLINICAL ONCOLOGY RENOVATION
The fight against cancer starts in the lab. That’s why we’ve invested in a renovation that doubled the size of our preclinical oncology facility in Ann Arbor, Michigan. Here you can discover enhanced capabilities and greater capacity to speed up your preclinical oncology programs.
4T1-luc2: An orthotopic mammary cancer odel to support novel immuno-oncology drug discovery
SPOTLIGHT TEMPLATE
Expanded PersistenceT™ panels for deeper analysis of CAR-T persistence
Plate-based 3D culture assays that mimic the tumor microenvironment and predict in vivo responses
Predictive Oncology® Reconstructed Bone (r-Bone)
Labcorp Drug Development Preclinical Oncology Biosafety Level 2 Capabilities and Ongoing Expansion
Exploring orthotopic glioblastoma models to treat tumors and strengthen immune responses in the brain
MB49 – a bladder cancer murine tumor model
BT-474 Human ductal breast carcinoma: New life for an old model
Determining preclinical CAR T-cell persistence by flow cytometry
Let's start a conversation
Contact Us
Labcorp is a leading global life sciences company that includes contract research and developmental services to the pharmaceutical, medical technology, crop protection and chemical industries.
.png){kind=icon}